Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 77.06% is in line with its 5-year average of 73.86%, near the high end of its 5-year range (72.11%–77.97%).
1.32% above its 12-month average of 76.06%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 77.97%.
GROSS MARGIN
77.06%
GROSS MARGIN AVG TTM
76.06%
GROSS MARGIN AVG 3Y
73.85%
GROSS MARGIN AVG 5Y
73.86%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.32%
CURRENT VS 3Y AVG
+4.35%
CURRENT VS 5Y AVG
+4.34%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
40.82%
median of 727 covered companies
CURRENT VS SECTOR MEDIAN
+88.78%
vs the sector median at left
Pulmonx Corporation
Market Cap
$77.93M
Gross Margin
77.06%
TTM Avg
76.06%
3Y Avg
73.85%
5Y Avg
73.86%
Market Cap
$79.46M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$78.31M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$83.67M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.39M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | $77.93M | 77.06% | 76.06% | 73.85% | 73.86% |
| Nutriband Inc. (NTRB)vs › | $81.81M | 33.14% | 30.24% | 34.48% | 35.28% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | 100.00% | 100.00% | 100.00% | 100.00% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.31M | 100.00% | 100.00% | 100.00% | 100.00% |
| LENSAR Inc (LNSR)vs › | $82.90M | 47.96% | 47.37% | 50.31% | 51.06% |
| Citius Oncology, Inc. (CTOR)vs › | $83.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| MediciNova, Inc. (MNOV)vs › | $82.45M | 7.58% | 3.79% | 26.89% | 34.60% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.39M | 0.00% | 0.00% | 0.00% | 0.00% |
| Hyperfine, Inc. (HYPR)vs › | $75.84M | 51.41% | 47.75% | 37.98% | -14.72% |
| Outset Medical, Inc. (OM)vs › | $76.10M | 41.76% | 36.53% | 27.69% | 15.34% |
Gross Margin
77.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 77.97% |
| 2026-03-31 | 77.94% |
| 2025-12-31 | 77.62% |
| 2025-09-30 | 74.65% |
| 2025-06-30 | 72.11% |
| 2025-03-31 | 72.51% |
| 2024-12-31 | 74.02% |
| 2024-09-30 | 73.70% |
| 2024-06-30 | 73.65% |
| 2024-03-31 | 74.14% |
| 2023-12-31 | 74.18% |
| 2023-09-30 | 73.74% |
| 2023-06-30 | 74.06% |
| 2023-03-31 | 72.85% |
| 2022-12-31 | 72.51% |
| 2022-09-30 | 75.19% |
| 2022-06-30 | 74.68% |
| 2022-03-31 | 75.21% |
| 2021-12-31 | 74.78% |
| 2021-09-30 | 73.44% |
| 2021-06-30 | 73.99% |
| 2021-03-31 | 71.52% |
| 2020-12-31 | 72.00% |
| 2020-09-30 | 70.32% |
| 2020-06-30 | 27.55% |
| 2020-03-31 | 65.56% |
| 2019-12-31 | 70.91% |
| 2019-09-30 | 70.38% |
| 2019-06-30 | 67.24% |
| 2019-03-31 | 65.96% |
